HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib.
| Image |  |
|---|---|
| Description | scientific article published on 3 May 2016 |
| Author/s |
author: Nathanael Gray Li Tan Zachary Hunter Steven P. Treon |
| Publication date | May 3, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |